Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1999 | 03-1999 | 12-1998 | 09-1998 | 06-1998 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,223,000 | 1,166,000 | 1,552,000 | 2,723,000 | 1,089,000 |
| Marketable Securities | 3,289,000 | 3,039,000 | 2,377,000 | 930,000 | 958,000 |
| Receivables | 3,396,000 | 3,470,000 | 2,914,000 | 2,860,000 | 3,110,000 |
| Inventories | 1,805,000 | 1,704,000 | 1,828,000 | 1,681,000 | 1,842,000 |
| Other current assets | 1,438,000 | 1,370,000 | 1,260,000 | 1,680,000 | 1,260,000 |
| TOTAL | $11,151,000 | $10,749,000 | $9,931,000 | $9,874,000 | $8,259,000 |
| Non-Current Assets | |||||
| PPE Net | 7,248,000 | 7,024,000 | N/A | 6,386,000 | 6,548,000 |
| Investments And Advances | 1,521,000 | 1,548,000 | 1,756,000 | 1,717,000 | 1,315,000 |
| Other Non-Current Assets | 2,230,000 | 2,197,000 | 2,200,000 | 2,471,000 | 2,768,000 |
| TOTAL | $10,999,000 | $10,769,000 | $3,956,000 | $10,574,000 | $10,631,000 |
| Total Assets | $19,640,000 | $19,025,000 | $18,302,000 | $18,177,000 | $16,508,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 770,000 | 656,000 | 971,000 | 817,000 | 814,000 |
| Accrued Expenses | 535,000 | 430,000 | 614,000 | 550,000 | 601,000 |
| Other current liabilities | 1,660,000 | 1,277,000 | 1,716,000 | 1,395,000 | 1,388,000 |
| TOTAL | $8,810,000 | $7,752,000 | $7,192,000 | $7,259,000 | $6,138,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 530,000 | 525,000 | 527,000 | 528,000 | 724,000 |
| Other Non-Current Liabilities | 1,464,000 | 1,539,000 | 1,576,000 | 1,304,000 | 1,243,000 |
| TOTAL | $2,179,000 | $2,228,000 | $2,300,000 | $2,273,000 | $2,065,000 |
| Total Liabilities | $10,989,000 | $9,980,000 | $9,492,000 | $9,532,000 | $8,203,000 |
| Shareholders' Equity | |||||
| Common Shares | 212,000 | 71,000 | 70,000 | 70,000 | 70,000 |
| Retained earnings | 12,367,000 | 12,254,000 | 11,439,000 | 11,325,000 | 9,928,000 |
| Other shareholders' equity | -3,906,000 | -4,574,000 | -4,434,000 | -4,061,000 | -4,136,000 |
| TOTAL | $8,651,000 | $9,045,000 | $8,810,000 | $8,645,000 | $8,305,000 |
| Total Liabilities And Equity | $19,640,000 | $19,025,000 | $18,302,000 | $18,177,000 | $16,508,000 |